News Release | Hisamitsu Pharmaceutical co.,inc.

2026.02.03 lR Information: (Amendment) Notice Regarding Commencement of Tender Offer by TAIYO KOSAN CO.,INC. for Share Certificates, Etc. of Hisamitsu Pharmaceutical Co., Inc. (Securities Code: 4530)

2026.01.07 lR Information: Announcement of Implementation of MBO and Recommendation for Tendering Shares

2026.01.07 lR Information: Notice Regarding Commencement of Tender Offer by TAIYO KOSAN CO.,INC. for Share Certificates, Etc. of Hisamitsu Pharmaceutical Co., Inc. (Securities Code: 4530)

2026.01.06 lR Information: FY02/2026 Q3 Results Earnings Release Presentation

2026.01.06 lR Information: Announcement on Revision of the Dividend Forecast for the Fiscal Year Ending February 28, 2026 (No Dividend)

2026.01.06 lR Information: Announcement on Withdrawal of the Earnings Forecast for the Fiscal Year Ending February 28, 2026

2026.01.05 Sustainability: Notice regarding The Decision to Contribute to Supporting Organizations in FY 2025 through Hisamitsu Pharmaceutical Co., Inc. Hot Heart Club